TARSUS PHARMACEUTICALS, INC.: net_income
| Value | {"amount": -26811000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | TARSUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7f6115d3-a220-43bf-8c92-f5764860ae35
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001819790-21-000010Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001819790/net-income/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7f6115d3-a220-43bf-8c92-f5764860ae35
History
- no predecessors — first report